Evidence map›Paper›PMID 33381932›Full record

ArticleYonsei medical journal2021

Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.

Jia Yu Lv, Ning Ning Zhang, Ya Wei Du, Ying Wu, Tian Qiang Song, Ya Min Zhang, Yan Qu, Yu Xin Liu, Jie Gu, Ze Yu Wang and 11 more

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Yonsei medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Jia Yu Lv *The First Central Clinical College of Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0002-8019-5025
Ning Ning Zhang *Liver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0001-9410-6639
Ya Wei DuLiver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0003-4533-2183
Ying WuSchool of Statistics and Data Science, Nankai University, Key Laboratory for Medical Data Analysis and Statistical Research of Tianjin, Tianjin, China.ORCID https://orcid.org/0000-0002-1012-8572
Tian Qiang SongLiver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0002-8710-6339
Ya Min ZhangDepartment of Hepatobiliary Surgery, Tianjin First Central Hospital, Tianjin Key Laboratory for Organ Transplantation, Tianjin, China.ORCID https://orcid.org/0000-0002-5376-5379
Yan QuSchool of Statistics and Data Science, Nankai University, Key Laboratory for Medical Data Analysis and Statistical Research of Tianjin, Tianjin, China.ORCID https://orcid.org/0000-0003-0392-8931
Yu Xin LiuSchool of Statistics and Data Science, Nankai University, Key Laboratory for Medical Data Analysis and Statistical Research of Tianjin, Tianjin, China.ORCID https://orcid.org/0000-0002-7521-720X
Jie GuThe First Central Clinical College of Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0001-7312-378X
Ze Yu WangLiver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0001-6264-634X
Yi Bo QiuThe First Central Clinical College of Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0002-8015-3175
Bing YangThe First Central Clinical College of Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0002-2537-6827
Da Zhi TianDepartment of Liver Transplantation, Tianjin First Central Hospital, NHC Key Laboratory for Critical Care Medicine, Key Laboratory of Transplantation, Chinese Academy of Medical Sciences, Tianjin, China.ORCID https://orcid.org/0000-0001-7640-2928
Qing Jun GuoDepartment of Liver Transplantation, Tianjin First Central Hospital, NHC Key Laboratory for Critical Care Medicine, Key Laboratory of Transplantation, Chinese Academy of Medical Sciences, Tianjin, China.ORCID https://orcid.org/0000-0002-2324-7167
Li ZhangDepartment of Liver Transplantation, Tianjin First Central Hospital, NHC Key Laboratory for Critical Care Medicine, Key Laboratory of Transplantation, Chinese Academy of Medical Sciences, Tianjin, China.ORCID https://orcid.org/0000-0002-6650-8742
Ji San SunDepartment of Liver Transplantation, Tianjin First Central Hospital, NHC Key Laboratory for Critical Care Medicine, Key Laboratory of Transplantation, Chinese Academy of Medical Sciences, Tianjin, China.ORCID https://orcid.org/0000-0003-3470-7090
Yan XieDepartment of Liver Transplantation, Tianjin First Central Hospital, NHC Key Laboratory for Critical Care Medicine, Key Laboratory of Transplantation, Chinese Academy of Medical Sciences, Tianjin, China.ORCID https://orcid.org/0000-0003-1096-1430
Zheng Lu WangDepartment of Liver Transplantation, Tianjin First Central Hospital, NHC Key Laboratory for Critical Care Medicine, Key Laboratory of Transplantation, Chinese Academy of Medical Sciences, Tianjin, China.ORCID https://orcid.org/0000-0001-6520-5515
Xin SunDepartment of Liver Transplantation, Tianjin First Central Hospital, NHC Key Laboratory for Critical Care Medicine, Key Laboratory of Transplantation, Chinese Academy of Medical Sciences, Tianjin, China.ORCID https://orcid.org/0000-0002-8977-1690
Wen Tao JiangDepartment of Liver Transplantation, Tianjin First Central Hospital, NHC Key Laboratory for Critical Care Medicine, Key Laboratory of Transplantation, Chinese Academy of Medical Sciences, Tianjin, China. jiangwentao1974@126.com.ORCID https://orcid.org/0000-0002-8026-9100
Wei LuLiver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0001-9467-3780
Chinese Academy of Medical Sciences & Peking Union Medical College · CNNankai University · CNTianjin Medical University · CNTianjin Medical University Cancer Institute and Hospital · CNTianjin First Center Hospital · CN

Funding

Tianjin Municipal Science and Technology Bureau 19YFZCSY00020
6 · The paper itself

Abstract

purposeThe aim of this study was to compare the efficacy of liver transplantation (LT) and liver resection (LR) for hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) and to investigate risk factors affecting prognosis. MATERIALS AND

methodsA total of 94 HCC patients with PVTT type I (segmental PVTT) and PVTT type II (lobar PVTT) were involved and divided into LR (n=47) and LT groups (n=47). Recurrence-free survival (RFS) and overall survival (OS) were compared before and after inverse probability of treatment weighting (IPTW). Prognostic factors for RFS and OS were explored.

resultsTwo treatment groups were well-balanced using IPTW. In the entire cohort, LT provided a better prognosis than LR. Among patients with PVTT type I, RFS was better with LT (

conclusionLT appeared to afford a better prognosis for HCC with PVTT type I than LR, especially in patients with AFP levels >200 ng/mL.

Indexed as

HepatectomyLiver TransplantationAdultalpha-FetoproteinsCarcinoma, HepatocellularFemaleHumansLiver NeoplasmsMaleMiddle AgedPortal VeinPrognosisRetrospective StudiesRisk FactorsThrombosisalpha-FetoproteinsHepatocellular carcinomaliver resectionliver transplantationportal vein tumor thrombus

Identifiers

PMID33381932
PMCPMC7820449
OpenAlexW3113572376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.